Jensen Investment Management Has Increased By $35.74 Million Its Stryker (SYK) Holding; 7 Analysts Are Bullish Theravance Biopharma (TBPH) Last Week

September 13, 2017 - By Nellie Frank

Jensen Investment Management Inc increased Stryker Corp (SYK) stake by 17.42% reported in 2016Q4 SEC filing. Jensen Investment Management Inc acquired 300,360 shares as Stryker Corp (SYK)’s stock rose 8.29%. The Jensen Investment Management Inc holds 2.02 million shares with $242.52 million value, up from 1.72 million last quarter. Stryker Corp now has $53.69B valuation. The stock decreased 0.11% or $0.16 during the last trading session, reaching $143.53. About shares traded. Stryker Corporation (NYSE:SYK) has risen 24.95% since September 13, 2016 and is uptrending. It has outperformed by 8.25% the S&P500.

Among 8 analysts covering Theravance Biopharma (NASDAQ:TBPH), 7 have Buy rating, 1 Sell and 0 Hold. Therefore 88% are positive. Theravance Biopharma had 14 analyst reports since August 12, 2015 according to SRatingsIntel. Needham maintained the shares of TBPH in report on Wednesday, August 2 with “Buy” rating. Leerink Swann initiated Theravance Biopharma Inc (NASDAQ:TBPH) on Thursday, May 12 with “Outperform” rating. The rating was initiated by Needham with “Buy” on Wednesday, December 21. Cantor Fitzgerald maintained it with “Buy” rating and $5500 target in Wednesday, July 19 report. Robert W. Baird downgraded Theravance Biopharma Inc (NASDAQ:TBPH) rating on Wednesday, October 12. Robert W. Baird has “Underperform” rating and $24 target. The firm has “Overweight” rating given on Thursday, November 3 by Piper Jaffray. The rating was initiated by Evercore on Wednesday, August 16 with “Buy”. Guggenheim initiated the shares of TBPH in report on Monday, June 20 with “Buy” rating. The stock of Theravance Biopharma Inc (NASDAQ:TBPH) earned “Neutral” rating by Robert W. Baird on Wednesday, August 12. The firm has “Buy” rating by Evercore given on Monday, August 29. See Theravance Biopharma Inc (NASDAQ:TBPH) latest ratings:

17/08/2017 Broker: Inc. – Ordinary Shares Rating: Evercore Isi Group
16/08/2017 Broker: Evercore Rating: Buy New Target: $45.0 Initiate
16/08/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $55.0 Maintain
02/08/2017 Broker: Needham Rating: Buy Maintain
19/07/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $55.0000 Maintain
16/06/2017 Broker: Inc. – Ordinary Shares Rating: Cantor Fitzgerald 55

Among 24 analysts covering Stryker Corporation (NYSE:SYK), 14 have Buy rating, 2 Sell and 8 Hold. Therefore 58% are positive. Stryker Corporation had 58 analyst reports since July 27, 2015 according to SRatingsIntel. As per Tuesday, September 22, the company rating was initiated by UBS. RBC Capital Markets maintained the shares of SYK in report on Friday, September 1 with “Buy” rating. The firm has “Hold” rating by Oppenheimer given on Friday, July 28. The stock has “Buy” rating by Canaccord Genuity on Wednesday, August 23. Citigroup initiated it with “Sell” rating and $88 target in Thursday, November 12 report. RBC Capital Markets maintained the shares of SYK in report on Wednesday, April 26 with “Outperform” rating. Stifel Nicolaus maintained Stryker Corporation (NYSE:SYK) rating on Tuesday, September 5. Stifel Nicolaus has “Buy” rating and $158.0 target. The rating was maintained by Oppenheimer with “Hold” on Monday, June 19. RBC Capital Markets maintained it with “Buy” rating and $14000 target in Tuesday, May 30 report. As per Tuesday, November 1, the company rating was upgraded by BMO Capital Markets.

Since May 1, 2017, it had 0 insider buys, and 4 selling transactions for $5.24 million activity. The insider Lobo Kevin sold $1.30 million. On Friday, June 2 Floyd David sold $1.07M worth of Stryker Corporation (NYSE:SYK) or 7,381 shares. On Monday, May 1 Scannell Timothy J sold $1.81M worth of Stryker Corporation (NYSE:SYK) or 13,322 shares.

Jensen Investment Management Inc decreased Johnson & Johnson (NYSE:JNJ) stake by 6,995 shares to 2.69M valued at $309.82M in 2016Q4. It also reduced 3M Company (NYSE:MMM) stake by 1,973 shares and now owns 2.03 million shares. Amphenol Corp. (NYSE:APH) was reduced too.

Investors sentiment decreased to 0.85 in 2016 Q4. Its down 0.04, from 0.89 in 2016Q3. It turned negative, as 50 investors sold SYK shares while 331 reduced holdings. 72 funds opened positions while 257 raised stakes. 277.34 million shares or 0.00% more from 277.33 million shares in 2016Q3 were reported. Clear Harbor Asset Mngmt Ltd Liability Corp stated it has 2,564 shares or 0.06% of all its holdings. Wendell David Associates reported 3.19% stake. Welch Group Ltd Liability Co stated it has 3,125 shares or 0.07% of all its holdings. Ny State Teachers Retirement invested in 519,971 shares or 0.16% of the stock. Synovus Fin holds 0.01% or 4,108 shares. Tokio Marine Asset Management, a Japan-based fund reported 6,345 shares. Principal Finance Group owns 461,383 shares for 0.07% of their portfolio. Allianz Asset Management Ag owns 632,952 shares for 0.07% of their portfolio. Moreover, National Planning has 0.02% invested in Stryker Corporation (NYSE:SYK) for 1,982 shares. Cullinan Incorporated stated it has 1,900 shares or 0.02% of all its holdings. Moreover, Tru Communications Of Vermont has 0.33% invested in Stryker Corporation (NYSE:SYK). Brown Brothers Harriman holds 0% or 3,122 shares. Canada Pension Plan Invest Board has 135 shares for 0% of their portfolio. Baxter Bros holds 0.18% in Stryker Corporation (NYSE:SYK) or 4,737 shares. Hutchin Hill Cap Lp, a New York-based fund reported 4,900 shares.

Investors sentiment increased to 1.78 in 2016 Q4. Its up 0.54, from 1.24 in 2016Q3. It improved, as 20 investors sold Theravance Biopharma Inc shares while 13 reduced holdings. 19 funds opened positions while 38 raised stakes. 31.87 million shares or 27.84% more from 24.93 million shares in 2016Q3 were reported. Jpmorgan Chase And Com holds 0% or 90,976 shares. Goldman Sachs Incorporated, a New York-based fund reported 58,048 shares. Sei Invs reported 8 shares or 0% of all its holdings. Wells Fargo And Mn reported 0% stake. Paloma Partners accumulated 0% or 13,478 shares. Millennium Ltd Liability Corporation holds 0% of its portfolio in Theravance Biopharma Inc (NASDAQ:TBPH) for 19,420 shares. Blackrock Inc reported 2,989 shares. 144,619 were accumulated by Blackrock Inv Llc. Rock Springs Mgmt Lp reported 1.28% in Theravance Biopharma Inc (NASDAQ:TBPH). Baupost Grp Inc Incorporated Limited Liability Corporation Ma holds 9.27 million shares or 3.85% of its portfolio. Bnp Paribas Arbitrage Sa has 0% invested in Theravance Biopharma Inc (NASDAQ:TBPH) for 2,693 shares. Point72 Asset L P accumulated 0.04% or 170,700 shares. Foundation Asset Limited Partnership invested 4.93% of its portfolio in Theravance Biopharma Inc (NASDAQ:TBPH). Franklin Inc reported 379,400 shares stake. State Board Of Administration Of Florida Retirement System, Florida-based fund reported 25,478 shares.